Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FS VH S/D vs TISSEEL VH in Cardiac Surgery
NCT00161733Phase 3Completed
- Sponsor
- Baxter
- Start
- Sep 2002
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of tisseel (2 arms), sponsored by Baxter. Primary endpoint: Achievement of hemostasis within 5 minutes. Started Sep 2002; status: completed.
02
Drugs
tisseel
Beyond the preview
Go deeper on NCT00161733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161733.